ROIV 8-K 2026-11-09

Roivant Sciences Ltd. (ROIV) 8-K dated 2026-11-09 — accession 0001635088-26-000130.

Roivant Sciences Ltd. (ROIV) is a biotechnology company listed on US.

ROIV: Roivant Reports Financial Results for the Second Quarter Ended Septembe…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 93.4% from 2024-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.

Not investment advice. The ROIV SEC hub lists recent forms. The stock page is the research view.